Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer – a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)
暂无分享，去创建一个
A. Reuss | J. Ledermann | F. Marmé | X. Paoletti | J. Sehouli | K. Lindemann | F. Heitz | P. Harter | E. Petru | A. Burges | P. Wimberger | E. Van Nieuwenhuysen | A. Redondo | D. Lorusso | C. Kurzeder | P. Pautier | N. Degregorio | Nadin Cron